X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24165) 24165
Book Chapter (274) 274
Newsletter (236) 236
Newspaper Article (148) 148
Magazine Article (136) 136
Publication (24) 24
Dissertation (18) 18
Conference Proceeding (11) 11
Government Document (7) 7
Reference (4) 4
Book / eBook (3) 3
Streaming Video (2) 2
Transcript (2) 2
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18613) 18613
science & technology (13249) 13249
life sciences & biomedicine (12603) 12603
male (10012) 10012
female (9846) 9846
heparin - administration & dosage (9555) 9555
heparin (7332) 7332
middle aged (6619) 6619
aged (5356) 5356
heparin - therapeutic use (5340) 5340
adult (5206) 5206
anticoagulants - administration & dosage (4928) 4928
animals (4603) 4603
cardiovascular system & cardiology (4157) 4157
anticoagulants - therapeutic use (3938) 3938
abridged index medicus (3815) 3815
heparin - adverse effects (3347) 3347
anticoagulants (3259) 3259
heparin - pharmacology (2712) 2712
treatment outcome (2687) 2687
anticoagulants - adverse effects (2628) 2628
hematology (2537) 2537
peripheral vascular disease (2481) 2481
time factors (2328) 2328
heparin, low-molecular-weight - administration & dosage (2308) 2308
cardiac & cardiovascular systems (2294) 2294
risk factors (2259) 2259
heparin, low-molecular-weight - therapeutic use (2065) 2065
surgery (2013) 2013
general & internal medicine (1716) 1716
thrombosis (1689) 1689
prospective studies (1547) 1547
rats (1498) 1498
dose-response relationship, drug (1489) 1489
aged, 80 and over (1478) 1478
retrospective studies (1416) 1416
thrombocytopenia - chemically induced (1373) 1373
pregnancy (1345) 1345
pharmacology & pharmacy (1330) 1330
thromboembolism (1318) 1318
postoperative complications - prevention & control (1311) 1311
drug therapy, combination (1301) 1301
fibrinolytic agents - therapeutic use (1263) 1263
injections, subcutaneous (1250) 1250
medicine, general & internal (1237) 1237
thromboembolism - prevention & control (1237) 1237
blood coagulation - drug effects (1227) 1227
fibrinolytic agents - administration & dosage (1219) 1219
hemorrhage - chemically induced (1193) 1193
thrombosis - prevention & control (1161) 1161
care and treatment (1141) 1141
adolescent (1133) 1133
drug therapy (1085) 1085
heparin, low-molecular-weight - adverse effects (1040) 1040
drug administration schedule (1009) 1009
partial thromboplastin time (1008) 1008
analysis (1003) 1003
mice (999) 999
injections, intravenous (995) 995
glycosaminoglycans (994) 994
medicine & public health (983) 983
infusions, intravenous (981) 981
research (977) 977
anticoagulants - pharmacology (976) 976
health aspects (960) 960
administration, oral (947) 947
follow-up studies (930) 930
dosage and administration (923) 923
blood coagulation tests (840) 840
anticoagulation (838) 838
low molecular weight heparin (823) 823
thrombosis - drug therapy (813) 813
venous thrombosis - drug therapy (809) 809
myocardial infarction - drug therapy (793) 793
venous thromboembolism (767) 767
thrombophlebitis - prevention & control (763) 763
recurrence (747) 747
pulmonary embolism - drug therapy (742) 742
pulmonary embolism (741) 741
pulmonary embolism - prevention & control (730) 730
venous thrombosis - prevention & control (730) 730
acute disease (724) 724
child (718) 718
low-molecular-weight heparin (712) 712
warfarin - administration & dosage (711) 711
clinical trials as topic (710) 710
patients (706) 706
respiratory system (701) 701
thrombosis - etiology (681) 681
warfarin - therapeutic use (677) 677
warfarin (673) 673
cardiopulmonary bypass (672) 672
thrombocytopenia (667) 667
thrombophlebitis - drug therapy (656) 656
aspirin - therapeutic use (653) 653
venous thromboembolism - prevention & control (648) 648
molecular weight (645) 645
randomized controlled trials as topic (639) 639
thrombolytic therapy (634) 634
risk assessment (621) 621
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22110) 22110
German (1039) 1039
Russian (598) 598
French (534) 534
Japanese (400) 400
Italian (184) 184
Spanish (184) 184
Polish (133) 133
Chinese (85) 85
Portuguese (56) 56
Czech (54) 54
Hungarian (49) 49
Danish (44) 44
Dutch (33) 33
Norwegian (31) 31
Swedish (31) 31
Bulgarian (23) 23
Romanian (15) 15
Korean (12) 12
Croatian (8) 8
Finnish (8) 8
Serbian (8) 8
Ukrainian (8) 8
Hebrew (7) 7
Turkish (7) 7
Lithuanian (5) 5
Slovak (4) 4
Persian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bosnian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 1524-4539, 02/2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e24S - e43S
This article describes the pharmacology of approved parenteral anticoagulants. These include the indirect anticoagulants, unfractionated heparin (UFH),... 
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Heparitin Sulfate - adverse effects | United States | Humans | Thrombin - antagonists & inhibitors | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Pipecolic Acids - administration & dosage | Chondroitin Sulfates - adverse effects | Societies, Medical | Pipecolic Acids - adverse effects | Heparitin Sulfate - administration & dosage | Polysaccharides - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Dermatan Sulfate - administration & dosage | Dermatan Sulfate - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Evidence-Based Medicine | Recombinant Proteins - administration & dosage | Antithrombins - agonists | Chondroitin Sulfates - administration & dosage | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Thrombosis - drug therapy | Heparin, Low-Molecular-Weight - administration & dosage | Infusions, Intravenous | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 22, pp. 2263 - 2269
Chronic kidney disease (CKD) is prevalent and affects an ever-increasing proportion of patients presenting with acute coronary syndrome (ACS). Patients with... 
Cardiovascular | Internal Medicine | non–ST-segment elevation myocardial infarction | chronic kidney disease | bleeding | ST-segment elevation myocardial infarction | unstable angina | acute coronary syndrome(s) | antiplatelet | antithrombotic | nonST-segment elevation myocardial infarction | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Piperazines - administration & dosage | Prasugrel Hydrochloride | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Heparin - administration & dosage | Thiophenes - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Acute Coronary Syndrome - complications | Aspirin - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Polysaccharides - administration & dosage | Kidney Diseases - complications | Platelet Aggregation Inhibitors - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Clinical Trials as Topic | Uremia - complications | Adenosine - administration & dosage | Piperazines - adverse effects | Recombinant Proteins - administration & dosage | Ticlopidine - analogs & derivatives | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Chronic Disease | Care and treatment | Chronic kidney failure | Cardiac patients | Cardiology | Coronary heart disease | Health aspects | Cardiovascular agents | Medical colleges | Mortality | Heart attacks | Drug therapy | Acute coronary syndromes | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2008, Volume 133, Issue 6, pp. 630S - 669S
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2011, Volume 377, Issue 9784, pp. 2193 - 2204
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 16, pp. 1941 - 1955
Abstract Venous thromboembolism (VTE) is a common disease associated with high risk for recurrences, death, and late sequelae, accounting for substantial... 
Cardiovascular | Internal Medicine | pulmonary embolism | anticoagulant agents | venous thrombosis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Venous Thromboembolism - mortality | Dabigatran - administration & dosage | Prognosis | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Thiazoles - administration & dosage | Rivaroxaban - administration & dosage | Venous Thromboembolism - drug therapy | Dose-Response Relationship, Drug | Clinical Trials, Phase III as Topic | Aged, 80 and over | Female | Venous Thromboembolism - diagnostic imaging | Drug Therapy, Combination | Pulmonary Embolism - diagnostic imaging | Severity of Illness Index | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Phlebography - methods | Treatment Outcome | Randomized Controlled Trials as Topic | Pulmonary Embolism - mortality | Anticoagulants - pharmacology | Survival Analysis | Pulmonary Embolism - drug therapy | Aged | Heparin, Low-Molecular-Weight - administration & dosage | Infusions, Intravenous | Pulmonary embolism | Stroke (Disease) | Anticoagulants (Medicine) | Drug therapy | Thromboembolism | Cardiovascular agents | Medical care, Cost of | Medical research | Medicine, Experimental | Respiratory agents | Anticoagulants | Fatalities | Health risk assessment | Patients | Mortality | Index Medicus | Abridged Index Medicus
Journal Article